Research programme: LRRK2 protein inhibitors - SandboxAQ/University of Dundee
Latest Information Update: 31 Oct 2024
At a glance
- Originator SandboxAQ; University of Dundee
- Class Antiparkinsonians
- Mechanism of Action LRRK2 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Parkinson's disease